ckd semaglutide Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial Novo's Ozempic wins FDA nod

Source References and Supplemental Research Nutrition Source

Obesity is a complex condition linked to chronic inflammation leading to the development of comorbidities such as metabolic syndrome, cardiovascular disease, type 2 diabetes (T2DM), non-alcoholic steatohepatitis or different types of tumors [1]

Thus, ACE2 plays a critical role in cardiopulmonary homeostasis through its vasoprotective function, and the ACE2/Ang-(17)/Mas 1 receptor signaling pathway is anticipated to be a promising therapeutic target for PAH (Papavassiliou et al., 2023)

In my practice I have seen patients make similar gains to semaglutide, even while staying on lower doses of tirzepatide

I love everyone and everything about this medical team and the care they give everyone

Cellular Health Protects cells from damage and supports healthy aging